Skip to main content

Reporter March 19 2021

Prostate cancer microenvironment

Mar. 23, 2021—Distinct cancer-associated fibroblasts in the prostate tumor microenvironment may influence tumor progression and could point to new therapeutic targets.

Read more


Chemo for cancer lowers dementia risk

Mar. 22, 2021—Cancer chemotherapy lowered risk of Alzheimer’s disease and other neurocognitive disorders that disproportionately affect older people.

Read more


COVID-19 and Cancer Consortium study highlights racial disparities, increased mortality for patients facing dual diagnoses

Mar. 19, 2021—The COVID-19 and Cancer Consortium (CCC19) published new findings in the Annals of Oncology showing heightened mortality and racial disparities for patients with cancer diagnosed with SARS-CoV-2 infection.

Read more


Strength training for osteoarthritis

Mar. 18, 2021—High-intensity strength training is not more effective than low-intensity training or educational efforts for reducing knee pain in patients with osteoarthritis.

Read more


HIV, diabetes and immune cells in fat

Mar. 18, 2021—In HIV-positive individuals with diabetes, immune cells in fat are more proinflammatory and cytotoxic and may represent a therapeutic target for diabetes.

Read more


Study to assess allergic reactions to COVID vaccines

Mar. 18, 2021—Vanderbilt University Medical Center is recruiting volunteers for a randomized controlled phase 2 clinical trial to help determine the prevalence of systemic allergic reactions (SARS) to the two-dose COVID-19 mRNA vaccines made by Pfizer-BioNTech and Moderna.

Read more


Clinic helps children with cerebral palsy regain mobility

Mar. 18, 2021—Seven-year-old Tinsley Bellar loves to dance — her mother describes it as TikTok dancing with cheerleader moves. She also loves to run. She completed her school’s fun run last year with the whole school cheering her on.

Read more


Vanderbilt research played key role in new lung screen guidelines

Mar. 18, 2021—The U.S. Preventive Services Task Force (USPSTF) has formally recommended two changes that will nearly double the number of people eligible for lung cancer screening by lowering the age from 55 to 50 and reducing the number of smoking history pack years from 30 to 20.

Read more


Device to treat AFib may eliminate need for blood thinners

Mar. 18, 2021—Vanderbilt University Medical Center is participating in a trial for a device that could revolutionize the way patients are treated for atrial fibrillation (AF or AFib.)

Read more


Orthopaedic Surgery offering virtual physical therapy

Mar. 18, 2021—The Department of Ortho-paedic Surgery has collaborated with Force Therapeutics, an episode-based digital care platform, to offer virtual physical therapy (PT) to patients recovering from surgery. This is an essential option during the pandemic when many patients are limiting their exposure to others.

Read more


Vanderbilt Orthopaedics team named best in Mt. Juliet

Mar. 18, 2021—The Vanderbilt Orthopaedics team at Mt. Juliet has been named best in orthopaedics by The Chronicle of Mt. Juliet for the fourth year in a row.

Read more


EGFR Resisters/LUNGevity fund lung cancer research

Mar. 18, 2021—Christine Lovly, MD, PhD, associate professor of Medicine in the Division of Hematology and Oncology and Ingram Professor of Cancer Research, is one of two inaugural recipients of the EGFR Resisters/LUNGevity Lung Cancer Research Award.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more